ZA938088B - 4-heterocyclyl-substituted dihydropyridines - Google Patents

4-heterocyclyl-substituted dihydropyridines

Info

Publication number
ZA938088B
ZA938088B ZA938088A ZA938088A ZA938088B ZA 938088 B ZA938088 B ZA 938088B ZA 938088 A ZA938088 A ZA 938088A ZA 938088 A ZA938088 A ZA 938088A ZA 938088 B ZA938088 B ZA 938088B
Authority
ZA
South Africa
Prior art keywords
heterocyclyl
substituted
dihydropyridines
substituted dihydropyridines
esterifying
Prior art date
Application number
ZA938088A
Other languages
English (en)
Inventor
Bodo Junge
Wolfgang Hartwig
Heinrich Meier
Rudolf Schone-Loop
Zhan Gao
Bernard Schmidt
Maarten De Jonge
Teunis Schuurman
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA938088B publication Critical patent/ZA938088B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA938088A 1992-10-30 1993-10-29 4-heterocyclyl-substituted dihydropyridines ZA938088B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4236707A DE4236707A1 (de) 1992-10-30 1992-10-30 4-Heterocyclyl substituierte Dihydropyridine

Publications (1)

Publication Number Publication Date
ZA938088B true ZA938088B (en) 1994-06-07

Family

ID=6471753

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938088A ZA938088B (en) 1992-10-30 1993-10-29 4-heterocyclyl-substituted dihydropyridines

Country Status (20)

Country Link
US (1) US5502064A (xx)
EP (1) EP0595166B1 (xx)
JP (1) JPH06220047A (xx)
KR (1) KR940009180A (xx)
CN (1) CN1094403A (xx)
AT (1) ATE153335T1 (xx)
AU (1) AU4873093A (xx)
CA (1) CA2109352A1 (xx)
CZ (1) CZ227693A3 (xx)
DE (2) DE4236707A1 (xx)
DK (1) DK0595166T3 (xx)
ES (1) ES2103412T3 (xx)
FI (1) FI934778A (xx)
GR (1) GR3024295T3 (xx)
HU (1) HUT68941A (xx)
IL (1) IL107414A0 (xx)
MX (1) MX9306509A (xx)
NO (1) NO933718L (xx)
SK (1) SK120793A3 (xx)
ZA (1) ZA938088B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525600A (en) * 1994-11-28 1996-06-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
EP2311806A3 (en) * 1996-01-29 2011-08-10 The United States of America, Represented by the Secretary, Department of Health and Human Services Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists
US6316423B1 (en) 1996-04-10 2001-11-13 The United States Of America As Represented By The Departmant Of Health And Human Services Method of treating ischemic, hypoxic and anoxic brain damage
KR100383514B1 (ko) * 2001-05-15 2003-05-12 한미반도체 주식회사 소형반도체 패키지 이송장치

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545873A1 (de) * 1965-11-10 1970-02-26 Bayer Ag Verfahren zur Herstellung von Dihydrodipyridylderivaten
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3239273A1 (de) * 1982-10-23 1984-04-26 Bayer Ag, 5090 Leverkusen Tetrahydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
DE3445356A1 (de) * 1983-12-15 1985-06-27 Ciba-Geigy Ag, Basel Halogenierte thiophen-verbindungen
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
DE3816361A1 (de) * 1987-05-18 1988-12-08 Byk Gulden Lomberg Chem Fab 1,4-dihydropyridindicarbonsaeure-(-)-menthylester

Also Published As

Publication number Publication date
DE59306506D1 (de) 1997-06-26
DK0595166T3 (da) 1997-12-01
CZ227693A3 (en) 1994-05-18
JPH06220047A (ja) 1994-08-09
ATE153335T1 (de) 1997-06-15
ES2103412T3 (es) 1997-09-16
KR940009180A (ko) 1994-05-20
EP0595166A1 (de) 1994-05-04
DE4236707A1 (de) 1994-05-05
EP0595166B1 (de) 1997-05-21
CA2109352A1 (en) 1994-05-01
MX9306509A (es) 1994-04-29
GR3024295T3 (en) 1997-10-31
NO933718D0 (no) 1993-10-15
HUT68941A (en) 1995-08-28
SK120793A3 (en) 1994-11-09
NO933718L (no) 1994-05-02
FI934778A0 (fi) 1993-10-28
AU4873093A (en) 1994-05-12
FI934778A (fi) 1994-05-01
HU9303083D0 (en) 1994-01-28
IL107414A0 (en) 1994-01-25
US5502064A (en) 1996-03-26
CN1094403A (zh) 1994-11-02

Similar Documents

Publication Publication Date Title
DE69022650D1 (de) Katalytisches Verfahren zur Herstellung von Carbonsäure und Carbonsäure-Estern.
ZA938088B (en) 4-heterocyclyl-substituted dihydropyridines
GR3019774T3 (en) Piperidylmethyl substituted chroman derivatives as agents for the treatment of diseases of the central nervous system
DK0525568T3 (da) N-Alkylerede 1,4-dihydropyridincarboxylsyreester
GR3023194T3 (en) Imidazole substituted phenylaceticacidprolinzamide derivatives.
GR3022166T3 (en) 4-heterocyclephenyl substituted dihydropyridines
HUT49869A (en) Process for producing 5-chloro-3-chlorosulfonyl-2-thiophenecarboxylic acid esters
SI0657431T1 (en) 4-Phenyl-3-substituted 1,4-dihydropyridine esters with cerebral activity
DE69206076D1 (de) Katalysatoren zur Herstellung von Kohlensäure-Ester und Verfahren zur Herstellung von Kohlensäureester.
AU7613594A (en) Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments
DE3679780D1 (de) Substituierte aminosulfonyl-6-nitrobenzosaeureester oder -amide, verfahren zur herstellung und diese enthaltende heilmittel.
EP0289307A3 (en) Optically active aromatic carboxylic acid derivatives and process for producing the same
EP0247779A3 (en) Process for the production of substituted 2-oxocyclo-hexaneacetic acid esters